CURAXIS PHARMACEUTICAL CORP Increase (Decrease) in Accrued Liabilities
CURAXIS PHARMACEUTICAL CORP reported Increase (Decrease) in Accrued Liabilities of $192.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2012-05-14
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accrued liabilities for the quarter ending 2012-03-31 was $192.00K, a 106.45% increase year-over-year.
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accrued liabilities for the quarter ending 2011-12-31 was $178.00K, a 584.62% increase year-over-year.
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accrued liabilities for the quarter ending 2011-09-30 was $177.00K, a 4325.00% increase year-over-year.
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accrued liabilities for the quarter ending 2011-06-30 was $169.00K.
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accrued liabilities for fiscal 2011 was $617.00K, a 5509.09% increase from fiscal 2010.
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accrued liabilities for fiscal 2010 was $11.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 41 month | Increase (Decrease) in Accrued Liabilities 127 month | Increase (Decrease) in Accrued Liabilities 130 month | Increase (Decrease) in Accrued Liabilities 133 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | $192.00K 10-Q · filed 2012-05-14 | $370.00K derived: sum of 2 quarters · filed 2012-05-14 | $547.00K derived: sum of 3 quarters · filed 2012-05-14 | $716.00K derived: sum of 4 quarters · filed 2012-05-14 | $3.26M 10-Q · filed 2012-05-14 | |||
| 2011-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $355.00K derived: sum of 2 quarters · filed 2012-03-29 | $524.00K derived: sum of 3 quarters · filed 2012-03-29 | $617.00K 10-K · filed 2012-03-29 | $3.07M 10-K · filed 2012-03-29 | |||
| 2011-09-30 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $346.00K derived: sum of 2 quarters · filed 2011-11-10 | $439.00K 10-Q · filed 2011-11-10 | $465.00K derived: sum of 4 quarters · filed 2012-05-14 | $2.89M 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-12 | $262.00K 10-Q · filed 2011-08-12 | $288.00K derived: sum of 3 quarters · filed 2012-05-14 | $292.00K derived: sum of 4 quarters · filed 2012-05-14 | $2.71M 10-Q · filed 2011-08-12 | |||
| 2011-03-31 | $93.00K 10-Q · filed 2012-05-14 | $119.00K derived: sum of 2 quarters · filed 2012-05-14 | $123.00K derived: sum of 3 quarters · filed 2012-05-14 | |||||
| 2010-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $30.00K derived: sum of 2 quarters · filed 2012-03-29 | $11.00K 10-K · filed 2012-03-29 | |||||
| 2010-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$15.00K 10-Q · filed 2011-11-10 | ||||||
| 2010-06-30 | -$19.00K 10-Q · filed 2011-08-12 |